Document:

<PAGE>
                                                                   EXHIBIT 10.11
                                                                  April __, 2000

Forstmann Little & Co. Equity Partnership - V, L.P.
767 Fifth Avenue, 44th Floor
New York, New York 10153

Dear Sirs:

      This letter will confirm our agreement that in connection with your
investment in Community Health Systems, Inc. (the "Company"), Forstmann Little &
Co. Equity Partnership - V, L.P. ("Investor"), will be entitled to the following
contractual management rights relating to the Company so long as Investor shall
own any voting securities of the Company (collectively, the
"Management Rights"):

(1)   Investor shall be entitled to consult with and advise management of the
      Company on significant business issues, including management's proposed
      annual operating plans, and management will meet with representatives of
      Investor (the "Representatives") at the Company's facilities at mutually
      agreeable times for such consultation and advice, including to review
      progress in achieving said plans. The Company shall give Investor
      reasonable advance written notice of any significant new initiatives or
      material changes to existing operating plans and shall afford Investor
      adequate time to meet with management to consult on such initiatives or
      changes prior to implementation. The Company agrees to give due
      consideration to the advice given and any proposals made by Investor;

(2)   Investor may inspect all contracts, books, records, personnel, offices and
      other facilities and properties of the Company and, to the extent
      available to the Company after the Company uses reasonable efforts to
      obtain them, the records of its legal advisors and accountants, including
      the accountants' work papers, and Investor may make such copies and
      inspections thereof as Investor may reasonably request. The Company shall
      furnish Investor with such financial and operating data and other
      information with respect to the business and properties of the Company as
      the Investor may request. The Company shall permit the Representatives to
      discuss the affairs, finances and accounts of the Company with, and to
      make proposals and furnish advice with respect thereto, the principal
      officers of the Company;

<PAGE>

(3)   Investor shall have the following rights regarding the appointment of a
      representative to the Company's Board of Directors (the "Board"). Investor
      shall provide to the Board, a reasonable period of time before the Board
      or the Company distributes to stockholders a proxy statement or other
      materials in connection with the election of directors, the name of
      Investor's nominee as director (the "Nominee"), as well as any other
      information regarding the Nominee as the Company may reasonably request.
      The selection by Investor of the Nominee shall be made after consultation
      with the Company, and Investor shall not designate a Nominee who is
      unsatisfactory to the existing directors. The Board and/or the Company
      shall include the Nominee as one of the persons recommended by the Board
      for election as a director of the Company, solicit proxies from
      stockholders in favor of the election of the Nominee as a director, and
      otherwise use all reasonable efforts to cause the Nominee to be elected as
      a director of the Company. In the event the Nominee elected to the Board
      shall cease to serve as a director for any reason, the Board shall fill
      the vacancy resulting therefrom with another Nominee. If the Company has a
      classified Board of Directors, Investor shall only be required to
      designate a Nominee, and the Company shall only be required to take steps
      to cause the Nominee to be elected, in the year in which the Nominee's
      class of directors is up for election. The Board shall not be required to
      fulfill its obligations under this paragraph to the extent that doing so
      would be in contravention of its fiduciary duties to the Company's
      stockholders; and

(4)   At any time during which Investor does not have a Representative on the
      Board, the Company shall, after receiving notice from Investor as to the
      identity of any Representative, (i) permit a Representative to attend all
      Board meetings and all committees thereof as an observer; (ii) provide the
      Representative advance notice of each such meeting, including such
      meeting's time and place, at the same time and in the same manner as such
      notice is provided to the members of the Board (or such committee thereof)
      and copies of all materials distributed to the members of the Board (or
      such committee thereof) at the same time as such materials are distributed
      to such Board (or such committee thereof) and shall permit the
      Representative to have the same access to information concerning the
      business and operations of the Company; and (iii) permit the
      Representative to discuss the affairs, finances and accounts of the
      Company with, and to make proposals and furnish advice with respect
      thereto to, the Board, without voting, and the Board and the Company's
      officers shall take such proposals or advice seriously and give due
      consideration thereto. Reasonable costs and expenses incurred by the
      Representative for the purposes of attending Board (or committee) meetings
      and conducting other Company business will be paid by the Company.

                                     - 2 -

<PAGE>

      Investor agrees, and shall cause each of its Representatives to agree, to
hold in confidence and trust and not use or disclose any confidential
information provided to or learned by it in connection with the exercise of
Investor's Management Rights under this letter agreement, unless otherwise
required by law or unless such confidential information otherwise becomes
publicly available or available to it other than through this letter agreement.

                                    Very truly yours,

                                    COMMUNITY HEALTH SYSTEMS, INC.

                                    By:
                                       ----------------------------
                                       Name:
                                       Title:

AGREED AND ACCEPTED THIS
__ day of April, 2000

FORSTMANN LITTLE & CO. EQUITY PARTNERSHIP - V, L.P.

By:   FLC XXX Partnership,
      its General Partner

By:
      ---------------------
      General Partner

                                     - 3 -
<PAGE>

                                                                  April __, 2000

Forstmann Little & Co. Subordinated Debt and Equity Management Buyout
Partnership - VI, L.P.
767 Fifth Avenue, 44th Floor
New York, New York 10153

Dear Sirs:

      This letter will confirm our agreement that in connection with your
investment in Community Health Systems, Inc. (the "Company"), Forstmann Little &
Co. Subordinated Debt and Equity Management Buyout Partnership - VI, L.P.
("Investor"), will be entitled to the following contractual management rights
relating to the Company so long as Investor shall own any voting securities of
the Company (collectively, the "Management Rights"):

(1)   Investor shall be entitled to consult with and advise management of the
      Company on significant business issues, including management's proposed
      annual operating plans, and management will meet with representatives of
      Investor (the "Representatives") at the Company's facilities at mutually
      agreeable times for such consultation and advice, including to review
      progress in achieving said plans. The Company shall give Investor
      reasonable advance written notice of any significant new initiatives or
      material changes to existing operating plans and shall afford Investor
      adequate time to meet with management to consult on such initiatives or
      changes prior to implementation. The Company agrees to give due
      consideration to the advice given and any proposals made by Investor;

(2)   Investor may inspect all contracts, books, records, personnel, offices and
      other facilities and properties of the Company and, to the extent
      available to the Company after the Company uses reasonable efforts to
      obtain them, the records of its legal advisors and accountants, including
      the accountants' work papers, and Investor may make such copies and
      inspections thereof as Investor may reasonably request. The Company shall
      furnish Investor with such financial and operating data and other
      information with respect to the business and properties of the Company as
      the Investor may request. The Company shall permit the Representatives to
      discuss the affairs, finances and accounts of the Company with, and to
      make proposals and furnish advice with respect thereto, the principal
      officers of the Company;

<PAGE>

(3)   Investor shall have the following rights regarding the appointment of a
      representative to the Company's Board of Directors (the "Board"). Investor
      shall provide to the Board, a reasonable period of time before the Board
      or the Company distributes to stockholders a proxy statement or other
      materials in connection with the election of directors, the name of
      Investor's nominee as director (the "Nominee"), as well as any other
      information regarding the Nominee as the Company may reasonably request.
      The selection by Investor of the Nominee shall be made after consultation
      with the Company, and Investor shall not designate a Nominee who is
      unsatisfactory to the existing directors. The Board and/or the Company
      shall include the Nominee as one of the persons recommended by the Board
      for election as a director of the Company, solicit proxies from
      stockholders in favor of the election of the Nominee as a director, and
      otherwise use all reasonable efforts to cause the Nominee to be elected as
      a director of the Company. In the event the Nominee elected to the Board
      shall cease to serve as a director for any reason, the Board shall fill
      the vacancy resulting therefrom with another Nominee. If the Company has a
      classified Board of Directors, Investor shall only be required to
      designate a Nominee, and the Company shall only be required to take steps
      to cause the Nominee to be elected, in the year in which the Nominee's
      class of directors is up for election. The Board shall not be required to
      fulfill its obligations under this paragraph to the extent that doing so
      would be in contravention of its fiduciary duties to the Company's
      stockholders; and

(4)   At any time during which Investor does not have a Representative on the
      Board, the Company shall, after receiving notice from Investor as to the
      identity of any Representative, (i) permit a Representative to attend all
      Board meetings and all committees thereof as an observer; (ii) provide the
      Representative advance notice of each such meeting, including such
      meeting's time and place, at the same time and in the same manner as such
      notice is provided to the members of the Board (or such committee thereof)
      and copies of all materials distributed to the members of the Board (or
      such committee thereof) at the same time as such materials are distributed
      to such Board (or such committee thereof) and shall permit the
      Representative to have the same access to information concerning the
      business and operations of the Company; and (iii) permit the
      Representative to discuss the affairs, finances and accounts of the
      Company with, and to make proposals and furnish advice with respect
      thereto to, the Board, without voting, and the Board and the Company's
      officers shall take such proposals or advice seriously and give due
      consideration thereto. Reasonable costs and expenses incurred by the
      Representative for the purposes of attending Board (or committee) meetings
      and conducting other Company business will be paid by the Company.

<PAGE>

      Investor agrees, and shall cause each of its Representatives to agree, to
hold in confidence and trust and not use or disclose any confidential
information provided to or learned by it in connection with the exercise of
Investor's Management Rights under this letter agreement, unless otherwise
required by law or unless such confidential information otherwise becomes
publicly available or available to it other than through this letter agreement.

                                    Very truly yours,

                                    COMMUNITY HEALTH SYSTEMS, INC.

                                    By:
                                       ----------------------------
                                       Name:
                                       Title:

AGREED AND ACCEPTED THIS
__ day of April, 2000

FORSTMANN LITTLE & CO. SUBORDINATED DEBT AND EQUITY MANAGEMENT BUYOUT
PARTNERSHIP - VI, L.P.

By:   FLC XXIX Partnership,
      its General Partner

By:
      ----------------------
      General Partner<PAGE>

                                                                   EXHIBIT 10.17

                         COMMUNITY HEALTH SYSTEMS, INC.
                         Employee Stock Purchase PROGRAM

                                    ARTICLE 1

                                     PURPOSE

COMMUNITY HEALTH SYSTEMS, INC. Employee Stock Purchase Program (the "Program")
is created for the purpose of encouraging stock ownership by employees of
COMMUNITY HEALTH SYSTEMS, INC. (the "Company") and its subsidiaries so that they
may share in the ownership of the Company by acquiring or increasing their
proprietary interest in the Company by purchasing shares of the Company on the
open market following the Company's initial public offering (the "IPO") with
amounts accumulated through payroll deductions.

                                    ARTICLE 2

                          ADMINISTRATION OF THE PROGRAM

The Program will be administered by a committee (the "Committee") appointed by
the Compensation Committee of the Board of Directors of the Company. The
Compensation Committee shall determine the number of members of the Committee
and, from time to time, may add or remove members from the Committee. The
Committee may select one of its members as chairperson and may hold meetings at
such times and places as it may determine. Acts by a majority of the Committee,
or acts approved in writing by a majority of the Committee, shall be the valid
acts of the Committee.

The interpretation and construction by the Committee of any provision of the
Program shall be final unless otherwise determined by the Compensation
Committee. The Committee may adopt, from time to time, such rules and
regulations as it deems appropriate for carrying out the Program. No member of
the Compensation Committee or the Committee shall be liable for any action or
determination made in good faith with respect to the Program.

In the event the Compensation Committee fails to appoint or refrains from
appointing a Committee, the Compensation Committee shall have the power and
authority to administer the Program. In such event, the term "Committee"
wherever used herein shall be deemed to mean the Compensation Committee.

<PAGE>

                                    ARTICLE 3

                               ELIGIBLE EMPLOYEES

All employees of the Company (including employees of its subsidiaries and
divisions) will be eligible to participate in the Program; PROVIDED, HOWEVER,
the Committee may designate that certain employees or classes of employees shall
not participate in the Program.

                                    ARTICLE 4

                             SHARES TO BE PURCHASED

The stock subject to purchase under the Program is common stock of the Company
(the "Shares") which will be purchased on the open market following the IPO.

                                    ARTICLE 5

                              COMPANY EXPENDITURES

The Company will limit its expenditures under the Program to those involved in
making payroll deductions and paying the reasonable administrative fees of the
broker or other agent designated from time to time by the Committee to purchase
Shares under the Program. The Company shall not pay for other transaction
charges involved in purchasing Shares or for the costs involved with a
participating employee's sale of Shares purchased under the Program. The Company
will not make any contributions to the Program or otherwise subsidize the cost
of acquiring Shares pursuant to the Program.

                                    ARTICLE 6

                               PAYROLL DEDUCTIONS

All Shares purchased under the Program shall be with amounts withheld from the
pay of participating employees through authorized payroll deductions.
Participating employee payroll deductions shall be in whole dollar increments of
the employee's base pay for any payroll period, with a minimum deduction of not
less than $10 per week and a maximum deduction not to exceed 10% of the
participating employee's gross base pay (exclusive of overtime and net of
withholding and other deductions). Participating employees may authorize
increases or decreases in the amount of payroll deductions by forwarding notice
of the change to the Company. Such change in the amount of the payroll
deductions shall be effective as soon as administratively practicable following
the receipt of such notice.

                                      -2-
<PAGE>

                                    ARTICLE 7

                     AUTHORIZATION FOR ENTERING THE PROGRAM

An eligible employee may enter the Program by completing, signing, and
delivering to the Company an authorization form provided by the Company. Such
authorization will take effect as soon as administratively practicable following
the receipt of the authorization form. Unless a participating employee
authorizes changes to his/her payroll deductions in accordance with Article 6 or
withdraws from the Program, his/her deductions under the latest authorization on
file with the Company shall continue from one payroll period to the succeeding
payroll period as long as the Program remains in effect.

                                    ARTICLE 8

                        REMITTANCE OF PAYROLL DEDUCTIONS

The Committee will establish one or more accounts under which it will credit to
each participant amounts deducted from the participant's pay pursuant to
Articles 6 and 7. No interest or other earnings shall be paid on such amounts.
The Company shall remit the accumulated payroll deductions to the designated
broker on a weekly basis for the purchase of Shares pursuant to Article 9 below.
The Committee or its designee (which may be the designated broker) shall provide
for the maintenance of suitable records to reflect the payroll deductions and
Shares purchased for each participating employee.

                                    ARTICLE 9

                               PURCHASE OF SHARES

Following the IPO, the designated broker shall purchase Shares under the Program
on the open market for any week at any time during that week or as soon as
administratively practicable following the receipt of the accumulated employee
payroll deductions and allocate such Shares (or fractions thereof) to individual
accounts maintained for each participating employee. In the event the purchase
of the Shares takes place over a number of days and at different prices, then
the Shares purchased for each participating employee shall be determined on the
basis of the average price per share over such period.

                                      -3-
<PAGE>

                                   ARTICLE 10

                         MAINTENANCE OF BROKER ACCOUNTS

The Shares purchased under the Program shall be held by the broker or its
nominee. Each participating employee shall receive a statement (not less
frequently than quarterly) issued by the broker which will evidence all activity
in his/her account.

                                   ARTICLE 11

                             RIGHTS AS A STOCKHOLDER

Following the purchase and allocation of Shares to a participating employee's
account, the participating employee shall have all of the rights and privileges
of a stockholder of the Company, and nothing in the Program shall be construed
as diminishing a participating employee's rights as a stockholder. As a
stockholder, each participating employee has the right to sell at any time all
or any portion of the Shares acquired under the Program and held by the broker.
All such sales of the Shares will be subject to compliance with any applicable
federal or state securities, tax, or other laws. All participating employees
assume the risk of fluctuations in the market price of the Shares.

                                   ARTICLE 12

                           WITHDRAWAL FROM THE PROGRAM

A participating employee may withdraw from the Program at any time by delivering
a notice of withdrawal to the Committee. Upon processing of any such written
notice, no further payroll deductions will be made from the participating
employee during subsequent payroll periods. Such participating employees payroll
deductions accumulated prior to the processing of such notice to stop
participation shall be applied toward purchasing Shares as provided in Sections
8 and 9 above. A participating employee may elect to resume participation in the
Program by providing an authorization form pursuant to Section 7 above;
PROVIDED, HOWEVER, that such participating employee may not resume participation
for a period of three months following his or her withdrawal from the Program.
Following such three-month period, an employee's election to resume
participation shall be effective as soon as administratively practicable
following the processing of such authorization form.

                                      -4-
<PAGE>

                                   ARTICLE 13

                            NO TRANSFER OR ASSIGNMENT

An employee's rights to purchase Shares under the Program through payroll
deductions are his or hers alone and may not be transferred or assigned to, or
availed of, by any other person.

                                   ARTICLE 14

                         TERMINATION OF EMPLOYEE RIGHTS

All of a participating employee's rights to purchase Shares under the Program
will terminate when he/she ceases to be an employee due to retirement,
resignation, death, termination, or for any other reason. A notice of withdrawal
will be deemed to have been received from an employee on the day his/her
employment ceases.

The Program shall not confer upon any participating employee any right to
continue in the employ of the Company or any subsidiary thereof.

                                   ARTICLE 15

                    TERMINATION AND AMENDMENT TO THE PROGRAM

The Program may be terminated at any time by the Committee. Upon such
termination or any other termination of the Program, all payroll deductions will
cease. The Committee may also amend the Program from time to time in any
respect.

                                      -5-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00008-of-00352.parquet"}]]